Estudos de modelagem molecular e relação estrutura atividade da oncoproteína hnRNP K e ligantes / Molecular modeling and structure activity relationship studies of the hnRNP K oncoprotein and ligands.

AUTOR(ES)

Vinicius Barreto da Silva

DATA DE PUBLICAÇÃO

2008

RESUMO

The Brazilian Project Genoma Câncer (PGHC) supported by FAPESP and the Ludwig Institute for Cancer Research, intended to identify the genes involved in the most common cases of cancer in Brazil. In this project about a million of gene sequences were identified. The major contribution was made in breast, colorectal and head and neck cancers. The results obtained stimulated the creation of another project, called Genoma Clínico, which intend to develop new trends in treatments and diagnosis of cancer based on the study of expressed genes. Analyzing healthy and neoplasic tissues in different stages, it is possible to identify molecular markers related to the prognosis of cancer, allowing the use of more efficient therapies. The hnRNP K protein was identified as a molecular marker in head and neck cancer, where the objective of this work lies in the application of bioinformatics and molecular modeling strategies by structure-based drug design to identify potential antineoplasic drug candicates that could act against hnRNP K protein. The hnRNP K protein is encountered in all cellular compartments and act, basically, in the gene expression pathways. Its structure is composed by three KH domains that mediate interactions with DNA and RNA molecules. High quality models of KH domains were built by homology modeling. After the virtual screening simulations performed with drug-like compound databases, containing approximately 330.000 compounds, 15 were selected as potential ligands of KH3 domain of hnRNP K. The binding modes suggested for these compounds, by docking simulations, presented a good spatial fit when compared with the virtual receptor sites calculated by molecular interaction fields. Molecular dynamics simulations were performed in order to evaluate de stability of the binding modes suggested. The potential ligands were also evaluated to identify toxicophoric features in its chemical structures.

ASSUNTO(S)

planejamento de fármacos baseado em estrutura structure-based drug design. screening virtual hnrnp k cancer virtual screening câncer hnrnp k molecular modeling modelagem molecular

Documentos Relacionados

• Modelagem molecular, síntese e avaliação da atividade biológica de potenciais antineoplásicos com a proteína hnRNP K e culturas de células tumorais
• Estudos de modelagem molecular e relação estrutura-atividade da acetilcolinesterase e inibidores em Mal de Alzheimer
• Molecular definition of heterogeneous nuclear ribonucleoprotein R (hnRNP R) using autoimmune antibody: immunological relationship with hnRNP P.
• Estudos funcionais e estruturais da proteina humana hnRNP Q/NSAP1
• Primary structure and binding activity of the hnRNP U protein: binding RNA through RGG box.